278
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Investigation of the cytotoxicity of nanozeolites A and Y

, , , , , , , & show all
Pages 472-485 | Received 16 Nov 2010, Accepted 08 May 2011, Published online: 27 Sep 2011

References

  • Adamis Z, Tatrai E, Honma K, Six E, Ungvary G. 2000. In vitro and in vivo tests for determination of the pathogenicity of quartz, diatomaceous earth, mordenite and clinoptilolite. Annals Occupat Hyg 44:67–74.
  • Alfaro-Moreno E, Nawrot TS, Vanaudenaerde BM, Hoylaerts MF, Vanoirbeek JA, Nemery B, Hoet PHM. 2008. Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur Respirat J 32:1184–1194.
  • Auffan M, Rose J, Orsiere T, De Meo M, Thill A, Zeyons O, Proux O, Masion A, Chaurand P, Spalla O, 2009. CeO2 nanoparticles induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 3:161–U115.
  • Baerlocher C, McCusker LB, Olson DH. 2007. Is an atlas. In: Atlas of zeolite framework types. 6th ed. Amsterdam: Elsevier.
  • Brinker CJ, Scherer GW. 1990. Particulate sols and gels. In: Sol-gel science: The physics and chemistry of sol-gel processing. 2nd ed. London: Academic Press.
  • Brunauer S, Emmett PH, Teller E. 1938. Adsorption of gases in multimolecular layers. J Am Chem Soc 60:309–319.
  • Caro J, Albrecht D, Noack M. 2009. Why is it so extremely difficult to prepare shape-selective Al-rich zeolite membranes like LTA and FAU for gas separation? Separat Purificat Technol 66:143–147.
  • Ceyhan T, Tatlier M, Akcakaya H. 2007. In vitro evaluation of the use of zeolites as biomaterials: Effects on simulated body fluid and two types of cells. J Mater Sci –Mater Med 18:1557–1562.
  • Cruz WV, Leung PCW, Seff K. 1978. Crystal-structures of cyclopropane complexes of cobalt(Ii) and manganese(Ii) in partially exchanged Zeolite-A. J Am Chem Soc 100:6997–7003.
  • Edgell CJ, McDonald CC, Graham JB. 1983. Permanent cell-line expressing human factor-VIII – related antigen established by hybridization. Proc Nat Acad Sci USA-Biolog Sci 80:3734–3737.
  • Fenoglio I, Croce A, Di Renzo F, Tiozzo R, Fubini B. 2000a. Pure-silica zeolites (porosils) as model solids for the evaluation of the physicochemical features determining silica toxicity to macrophages. Chem Res Toxicol 13:489–500.
  • Fenoglio I, Fubini B, Tiozzo R, Di Renzo F. 2000b. Effect of micromorphology and surface reactivity of several unusual forms of crystalline silica on the toxicity to a monocyte-macrophage tumor cell line. Inhalat Toxicol 12:81–89.
  • Fubini B. 1998. Health effects of silica. In: Legrand AP, editor. The surface properties of silicas. Chichester, UK: John Wiley & Sons. pp 415–465.
  • Fubini B, Ghiazza M, Fenoglio I. 2010. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 4:347–363.
  • Ghobarkar H, Schaf O, Guth U. 1999. Zeolites – from kitchen to space. Prog Solid State Chem 27:29–73.
  • Gonzalez L, Thomassen LCJ, Plas G, Rabolli V, Napierska D, Decordier I, Roelants M, Hoet PH, Kirschhock CEA, Martens JA, 2010. Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models. Nanotoxicology 4:382–395.
  • Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Fukagawa NK, Mossman BT. 2010. Assessing nanotoxicity in cells in vitro. Wiley Interdisciplinary Reviews – Nanomed Nanobiotechnol 2:219–231.
  • Holmberg BA, Wang HT, Norbeck JM, Yan YS. 2003. Controlling size and yield of zeolite Y nanocrystals using tetramethylammonium bromide. Micropor Mesopor Mater 59:13–28.
  • Holmberg BA, Wang H, Yan YS. 2004. High silica zeolite Y nanocrystals by dealumination and direct synthesis. Micropor Mesopor Mater 74:189–198.
  • Iler RK. 1981. The surface chemistry of amorphous synthetic silica: Interaction with organic molecules in an aqueous medium. In: Dunnom DD, editor. Health effects of synthetic silica particulates: Philadelphia: American Society for Testing and Materials. pp 3–21.
  • Klaine SJ, Alvarez PJJ, Batley GE, Fernandes TF, Handy RD, Lyon DY, Mahendra S, McLaughlin MJ, Lead JR. 2008. Nanomaterials in the environment: Behavior, fate, bioavailability, and effects. Environ Toxicol Chem 27:1825–1851.
  • Kuzniatsova T, Kim Y, Shqau K, Dutta PK, Verweij H. 2007. Zeta potential measurements of zeolite Y: Application in homogeneous deposition of particle coatings. Micropor Mesopor Mater 103:102–107.
  • Li QH, Creaser D, Sterte J. 2002. An investigation of the nucleation/crystallization kinetics of nanosized colloidal faujasite zeolites. Chem Mater 14:1319–1324.
  • Li HR, Devaux A, Popovic Z, De Cola L, Calzaferri G. 2006. Carboxyester functionalised dye-zeolite L host-guest materials. Micropor Mesopor Mater 95:112–117.
  • Loveland BE, Johns TG, Mackay IR, Vaillant F, Wang ZX, Hertzog PJ. 1992. Validation of the Mtt dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Int 27:501–510.
  • Maurer T, Muller SP, Kraushaar-Czarnetzki B. 2001. Aggregation and peptization behavior of zeolite crystals in sols and suspensions. Industrial Engineer Chem Res 40:2573–2579.
  • Mintova S, Olson NH, Bein T. 1999a. Electron microscopy reveals the nucleation mechanism of zeolite Y from precursor colloids. Angewandte Chemie-Int Ed 38:3201–3204.
  • Mintova S, Olson NH, Valtchev V, Bein T. 1999b. Mechanism of zeolite a nanocrystal growth from colloids at room temperature. Science 283:958–960.
  • Napierska D, Thomassen LCJ, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH. 2009. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5:846–853.
  • Napierska D, Thomassen LCJ, Lison D, Martens JA, Hoet PH. 2010. The nanosilica hazard: Another variable entity. Particle Fibre Toxicol 7.
  • Nikolakis V. 2005. Understanding interactions in zeolite colloidal suspensions: A review. Curr Opin Colloid Interface Sci 10:203–210.
  • Ndiege N, Raidoo R, Schultz MK, Larsen S. 2011. Preparation of a versatile bifunctional zeolite for targeted imaging applications. Langmuir 27:2904–2909.
  • Oberdörster G. 2000. Toxicology of ultrafine particles: In vivo studies. Philosoph Transact Royal Soc London Series A – Math Phys Engineer Sci 358:2719–2739.
  • Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839.
  • Pearce ME, Mai HQ, Lee N, Larsen SC, Salem AK. 2008. Silicalite nanoparticles that promote transgene expression. Nanotechnology 19.
  • Petushkov A, Intra J, Graham JB, Larsen SC, Salem AK. 2009. Effect of crystal size and surface functionalization on the cytotoxicity of silicalite – 1 Nanoparticles. Chem Res Toxicol 22:1359–1368.
  • Petushkov A, Freeman J, Larsen SC. 2010a. Framework stability of nanocrystalline NaY in aqueous solution at varying pH. Langmuir 26:6695–6701.
  • Petushkov A, Ndiege N, Salem AK, Larsen SC. 2010b. Toxicity of silica nanomaterials: Zeolites, mesoporous silica, and amorphous silica nanoparticles. In: Fishbein JC, editor. Advances in molecular toxicology. Amsterdam: Elsevier. p 223.
  • Rabolli V, Thomassen LCJ, Princen C, Napierska D, Gonzalez L, Kirsch-Volders M, Hoet PH, Huaux F, Kirschhock CEA, Martens JA, 2010. Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types. Nanotoxicology 4:307–318.
  • Schoeman BJ, Sterte J, Otterstedt JE. 1994. Colloidal zeolite suspensions. Zeolites 14:110–116.
  • Seaton A, Tran L, Aitken R, Donaldson K. 2010. Nanoparticles, human health hazard and regulation. J Royal Soc Interface 7:S119–129.
  • Singh S, Shi TM, Duffin R, Albrecht C, van Berlo D, Hoehr D, Fubini B, Martra G, Fenoglio I, Borm PJA, 2007. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: Role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharmacol 222:141–151.
  • Slowing II, Wu CW, Vivero-Escoto JL, Lin VSY. 2009. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5:57–62.
  • Stern ST, McNeil SE. 2008. Nanotechnology safety concerns revisited. Toxicolog Sci 101:4–21.
  • Stoeger T, Takenaka S, Frankenberger B, Ritter B, Karg E, Maier K, Schulz H, Schmid O. 2009. Deducing in vivo toxicity of combustion-derived nanoparticles from a cell-free oxidative potency assay and metabolic activation of organic compounds. Environ Health Perspect 117:54–60.
  • Stone V, Johnston H, Schins RPF. 2009. Development of in vitro systems for nanotoxicology: Methodological considerations. Crit Rev Toxicol 39:613–626.
  • Suh WH, Suslick KS, Stucky GD, Suh YH. 2009. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol 87:133–170.
  • Thomassen LCJ, Aerts A, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Napierska D, Hoet PH, Kirschhock CEA, Martens JA. 2010. Synthesis and characterization of stable monodisperse silica nanoparticle sols for in vitro cytotoxicity testing. Langmuir 26:328–335.
  • Tosheva L, Valtchev VP. 2005. Nanozeolites: Synthesis, crystallization mechanism, and applications. Chem Materials 17:2494–2513.
  • Tsotsalas M, Busby M, Gianolio E, Aime S, De Cola L. 2008. Functionalized nanocontainers as dual magnetic and optical probes for molecular imaging applications. Chem Materials 20:5888–5893.
  • Tsotsalas MM, Kopka K, Luppi G, Wagner S, Law MP, Schafers M, De Cola L. 2010. Encapsulating In-111 in nanocontainers for scintigraphic imaging: Synthesis, characterization, and in vivo biodistribution. ACS Nano 4:342–348.
  • Vermeiren W, Gilson JP. 2009. Impact of zeolites on the petroleum and petrochemical industry. Top Catalysis 52:1131–1161.
  • Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicolog Sci 101:183–185.
  • Worle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6:1261–1268.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.